Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin doesn't stop hair loss.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

Collider bias can distort our understanding of COVID-19 risk and severity.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Chemokine signaling is important for hair development.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.